BARBARA A WOOD
CIK 1220051 · EVP, Gen. Counsel, Corp. Sec. · last filed 2024-01-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.51M
Companies
3
Total Filings
40
Lifetime Open-Market Net
-$2.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLS | EVP, Gen. Counsel, Corp. Sec. | 117,225 | $12.88 | $1.51M | -$10.9K | 11 | 2024-01-25 |
| IVERIC bio, Inc. (OPHT) Delisted | SVP, Gen. Counsel, Secretary | 16,462 | — | — | -$684.8K | 17 | 2018-01-05 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Sr. V.P. & General Counsel | 0 | — | — | -$1.35M | 12 | 2010-06-09 |
Recent Filings · Page 4 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-03-03 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Mixed | — | -$384.7K | EDGAR |
| 2009-12-18 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Mixed | +4,378 | -$20.5K | EDGAR |
| 2009-12-15 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Tax (F) | −1,089 | -$37.8K | EDGAR |
| 2009-07-16 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Tax (F) | −519 | -$15.8K | EDGAR |
| 2008-12-18 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2008-12-16 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Tax (F) | −993 | -$33.2K | EDGAR |
| 2008-07-16 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Tax (F) | −473 | -$21.2K | EDGAR |
| 2007-12-26 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Mixed | — | -$87.6K | EDGAR |
| 2007-12-14 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Mixed | +5,027 | -$22.6K | EDGAR |
| 2007-10-29 | OSI PHARMACEUTICALS INC (OSIP) Delisted | Sell (S) | −2,398 | -$100.7K | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.